ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 8 filers reported holding ODONATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $160,000 | +213.7% | 118,871 | +568.9% | 0.00% | – |
| Q3 2021 | $51,000 | +15.9% | 17,771 | +42.1% | 0.00% | – |
| Q2 2021 | $44,000 | -29.0% | 12,507 | -31.0% | 0.00% | – |
| Q1 2021 | $62,000 | -46.1% | 18,138 | +203.7% | 0.00% | – |
| Q4 2020 | $115,000 | +62.0% | 5,972 | +11.8% | 0.00% | – |
| Q3 2020 | $71,000 | -93.8% | 5,341 | -80.1% | 0.00% | – |
| Q2 2020 | $1,138,000 | +54.4% | 26,867 | +0.5% | 0.00% | – |
| Q1 2020 | $737,000 | -14.6% | 26,735 | +0.6% | 0.00% | – |
| Q4 2019 | $863,000 | -0.5% | 26,580 | -20.1% | 0.00% | – |
| Q3 2019 | $867,000 | +230.9% | 33,270 | +366.9% | 0.00% | – |
| Q2 2019 | $262,000 | +244.7% | 7,126 | +109.6% | 0.00% | – |
| Q1 2019 | $76,000 | -7.3% | 3,400 | -42.3% | 0.00% | – |
| Q4 2018 | $82,000 | +156.2% | 5,892 | +251.6% | 0.00% | – |
| Q3 2018 | $32,000 | +39.1% | 1,676 | +58.4% | 0.00% | – |
| Q2 2018 | $23,000 | +76.9% | 1,058 | +79.3% | 0.00% | – |
| Q1 2018 | $13,000 | – | 590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |